L & S Advisors Inc decreased its holdings in Medtronic plc (NYSE:MDT) by 2.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 69,889 shares of the medical technology company’s stock after selling 2,085 shares during the period. Medtronic plc comprises about 1.1% of L & S Advisors Inc’s investment portfolio, making the stock its 21st biggest holding. L & S Advisors Inc’s holdings in Medtronic plc were worth $6,203,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the business. Hudock Capital Group LLC grew its holdings in shares of Medtronic plc by 0.5% in the second quarter. Hudock Capital Group LLC now owns 2,195 shares of the medical technology company’s stock worth $194,000 after acquiring an additional 11 shares during the period. Bollard Group LLC grew its holdings in shares of Medtronic plc by 0.4% in the second quarter. Bollard Group LLC now owns 3,651 shares of the medical technology company’s stock worth $324,000 after acquiring an additional 14 shares during the period. Triangle Securities Wealth Management grew its holdings in shares of Medtronic plc by 0.3% in the second quarter. Triangle Securities Wealth Management now owns 4,396 shares of the medical technology company’s stock worth $390,000 after acquiring an additional 15 shares during the period. IFC Holdings Incorporated FL grew its holdings in shares of Medtronic plc by 0.3% in the second quarter. IFC Holdings Incorporated FL now owns 5,673 shares of the medical technology company’s stock worth $501,000 after acquiring an additional 17 shares during the period. Finally, North Star Investment Management Corp. grew its holdings in shares of Medtronic plc by 1.1% in the second quarter. North Star Investment Management Corp. now owns 1,995 shares of the medical technology company’s stock worth $177,000 after acquiring an additional 22 shares during the period. 81.37% of the stock is owned by institutional investors and hedge funds.

Shares of Medtronic plc (NYSE MDT) opened at $79.49 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.64 and a quick ratio of 1.40. The company has a market capitalization of $106,580.00, a PE ratio of 16.88, a P/E/G ratio of 2.16 and a beta of 1.00. Medtronic plc has a 52-week low of $69.35 and a 52-week high of $89.72.

Medtronic plc (NYSE:MDT) last posted its earnings results on Tuesday, August 22nd. The medical technology company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.04. The company had revenue of $7.39 billion for the quarter, compared to the consensus estimate of $7.44 billion. Medtronic plc had a return on equity of 12.92% and a net margin of 13.75%. The firm’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.03 earnings per share. analysts anticipate that Medtronic plc will post 4.7 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, October 20th. Investors of record on Friday, September 29th were given a $0.46 dividend. The ex-dividend date was Thursday, September 28th. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.31%. Medtronic plc’s dividend payout ratio is currently 61.95%.

In related news, EVP Bryan C. Hanson sold 16,000 shares of the business’s stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $79.02, for a total value of $1,264,320.00. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Omar Ishrak sold 140,407 shares of the business’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $81.63, for a total value of $11,461,423.41. Following the completion of the sale, the chief executive officer now owns 668,503 shares in the company, valued at $54,569,899.89. The disclosure for this sale can be found here. Insiders sold 172,407 shares of company stock worth $13,974,223 over the last quarter. 0.31% of the stock is owned by company insiders.

Several analysts recently commented on the company. BidaskClub lowered Medtronic plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Zacks Investment Research lowered Medtronic plc from a “hold” rating to a “sell” rating in a report on Monday, July 31st. Deutsche Bank AG set a $96.00 price objective on Medtronic plc and gave the stock a “buy” rating in a report on Monday, July 31st. Cowen and Company set a $95.00 price objective on Medtronic plc and gave the stock a “buy” rating in a report on Tuesday, August 22nd. Finally, Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and issued a $92.00 price objective on shares of Medtronic plc in a report on Tuesday, August 22nd. Three analysts have rated the stock with a sell rating, ten have given a hold rating and thirteen have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $87.88.

WARNING: “Medtronic plc (MDT) Shares Sold by L & S Advisors Inc” was published by Watch List News and is the sole property of of Watch List News. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.watchlistnews.com/medtronic-plc-mdt-shares-sold-by-l-s-advisors-inc/1711243.html.

Medtronic plc Company Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Institutional Ownership by Quarter for Medtronic plc (NYSE:MDT)

Receive News & Ratings for Medtronic plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic plc and related companies with Analyst Ratings Network's FREE daily email newsletter.